Eliminating breast surgery for triple negative or HR-/HER2+ breast cancer patients with clinical complete response to combined neoadjuvant chemotherapy and neoadjuvant radiotherapy: A multicenter, phase 2 trial (EBCS).

Authors: Zhengjun Yang, Xin Wang, Xuchen Cao, Aoxiang Chen, Qingsong Pang, Jing Wang, Hong Lu, Ying Zhu, Xiaojing Guo, Fengxia Qin, Xiaolong Qian, Jiangrui Chi, Lin Li, Qian Li

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps630

Source: Full article

---

Abstract

TPS630